HUP0101706A3 - Use of 1'-[4-[1-(4-fluorphenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzo-furan-1(3h),4'-piperidine] for the preparation of pharmaceutical composition treating panic attacks - Google Patents

Use of 1'-[4-[1-(4-fluorphenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzo-furan-1(3h),4'-piperidine] for the preparation of pharmaceutical composition treating panic attacks

Info

Publication number
HUP0101706A3
HUP0101706A3 HU0101706A HUP0101706A HUP0101706A3 HU P0101706 A3 HUP0101706 A3 HU P0101706A3 HU 0101706 A HU0101706 A HU 0101706A HU P0101706 A HUP0101706 A HU P0101706A HU P0101706 A3 HUP0101706 A3 HU P0101706A3
Authority
HU
Hungary
Prior art keywords
isobenzo
fluorphenyl
spiro
indole
furan
Prior art date
Application number
HU0101706A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HUP0101706A2 publication Critical patent/HUP0101706A2/hu
Publication of HUP0101706A3 publication Critical patent/HUP0101706A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0101706A 1998-04-07 1999-03-30 Use of 1'-[4-[1-(4-fluorphenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzo-furan-1(3h),4'-piperidine] for the preparation of pharmaceutical composition treating panic attacks HUP0101706A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK50198 1998-04-07
PCT/DK1999/000190 WO1999051229A1 (en) 1998-04-07 1999-03-30 Treatment of panic attacks

Publications (2)

Publication Number Publication Date
HUP0101706A2 HUP0101706A2 (hu) 2001-11-28
HUP0101706A3 true HUP0101706A3 (en) 2003-03-28

Family

ID=8094284

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101706A HUP0101706A3 (en) 1998-04-07 1999-03-30 Use of 1'-[4-[1-(4-fluorphenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzo-furan-1(3h),4'-piperidine] for the preparation of pharmaceutical composition treating panic attacks

Country Status (23)

Country Link
US (1) US6262061B1 (hu)
EP (1) EP1069899A1 (hu)
JP (1) JP2002510626A (hu)
KR (1) KR20010042502A (hu)
CN (1) CN1296409A (hu)
AR (1) AR019023A1 (hu)
AU (1) AU3025899A (hu)
BG (1) BG104814A (hu)
BR (1) BR9909598A (hu)
CA (1) CA2325948A1 (hu)
EA (1) EA200001032A1 (hu)
HR (1) HRP20000659A2 (hu)
HU (1) HUP0101706A3 (hu)
ID (1) ID28335A (hu)
IL (1) IL138484A0 (hu)
IS (1) IS5636A (hu)
NO (1) NO20005062L (hu)
PL (1) PL342989A1 (hu)
SK (1) SK14842000A3 (hu)
TR (1) TR200002891T2 (hu)
WO (1) WO1999051229A1 (hu)
YU (1) YU58900A (hu)
ZA (1) ZA200004856B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU18701A (sh) * 1998-09-15 2003-07-07 H. Lundbeck A/S. Tretiranje depresije
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
WO2004110388A2 (en) * 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
EA200001032A1 (ru) 2001-04-23
IL138484A0 (en) 2001-10-31
WO1999051229A1 (en) 1999-10-14
AR019023A1 (es) 2001-12-26
YU58900A (sh) 2002-11-15
CA2325948A1 (en) 1999-10-14
KR20010042502A (ko) 2001-05-25
TR200002891T2 (tr) 2001-02-21
JP2002510626A (ja) 2002-04-09
NO20005062D0 (no) 2000-10-06
BR9909598A (pt) 2000-11-21
AU3025899A (en) 1999-10-25
US6262061B1 (en) 2001-07-17
BG104814A (en) 2001-04-30
IS5636A (is) 2000-09-22
CN1296409A (zh) 2001-05-23
HRP20000659A2 (en) 2001-04-30
NO20005062L (no) 2000-11-30
ID28335A (id) 2001-05-10
HUP0101706A2 (hu) 2001-11-28
PL342989A1 (en) 2001-07-16
ZA200004856B (en) 2001-08-29
EP1069899A1 (en) 2001-01-24
SK14842000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
WO1999063976A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
HK1034075A1 (en) 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl]-1-butyl]-spiro [isobenzofuran-1(3h),4'-piperidine] hydrohalogenides
HUP9901389A3 (en) Piperidine and pyrrolidine derivatives acting for the central nervous system, pharmaceutical compositions containing these compounds, preparation and use thereof
HK1041827A1 (en) Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame.
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
PL333695A1 (en) Derivatives or di- or triaza spiro [3,5]nonane, method of obtaining them and therapeutic agents containing such compounds
HUP0003219A3 (en) Phthalazine derivatives, process for producing them and pharmaceutical compositions containing them and use of the compounds for producing pharmaceutical compositions useful for treating erectile dysfunction
HUP0100214A3 (en) Ophthalmic composition containing quinazolin derivatives and their producing
EP1051169A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRAL INFECTIONS AND RELATED DISEASES
HUP0101482A3 (en) Piperidinyl and n-amidinopiperidinyl derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
HUP0101706A3 (en) Use of 1'-[4-[1-(4-fluorphenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzo-furan-1(3h),4'-piperidine] for the preparation of pharmaceutical composition treating panic attacks
AU1530195A (en) Halogenated derivatives of 2,3'-(o)-cyclocytidine compounds and process for production thereof
AU1054500A (en) N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists
IL161949A0 (en) Pharmaceutical compositions containing 3,4-propinoperhydropurines and usesthereof for blocking neuronal transmissi
PL333693A1 (en) Derivatives or di- or triaza spiro[4,5]decane, method of obtaining them and therapeutic agents containing such compounds
AU5003996A (en) Homochiral compounds for the preparation of ketoconazole, terconazole and related antifungal drugs
IL140417A0 (en) NOVEL COMPOUNDS DERIVED FROM β-D-XYLOSE, PREPARATION METHOD AND THERAPEUTIC USE
WO2001046178A3 (en) Substituierte bisindolymaleimide
HUP0103569A3 (en) New medicament and process for its preparation
AU2001279607A1 (en) Pharmaceutical composition containing 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl) -1-butyl)-spiro(isobenzofuran-1(3h),4'-piperidine)
HUP0102116A3 (en) Paroxetine ascorbate, process for its preparation and its pharmaceutical use
AU5330599A (en) Methods and compositions for treating and preventing certain psychiatric and medical disorders using moclobemide
IL141947A0 (en) Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds
AU1764300A (en) Novel derivatives of swainsonine, processes for their preparation, and their useas therapeutic agents
HUP0104416A3 (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system and medicaments containing the compounds